Article
EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect.
Clinical lung cancer - 1 Jan 2016
Sahnane Nora, Frattini Milo, Bernasconi Barbara, Zappa Francesco, Schiavone Giovanna, Wannesson Luciano, Antonelli Paola, Balzarini Piera, Sessa Fausto, Mazzucchelli Luca, Tibiletti Maria Grazia, Martin Vittoria
Abstract excerpt
INTRODUCTION: In lung adenocarcinoma (ADC), anaplastic lymphoma receptor tyrosine kinase (ALK) rearrangements are mutually exclusive with epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations. However, the existence of double-positive (DP) patients have been sporadically described. We identified DP cases in therapy-naive ALK-rearranged ADC and characterized the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
